The core purpose of the Association of Community Cancer Centers (ACCC) is to be the leading education and advocacy organization for the cancer team. ACCC promotes the entire continuum of quality cancer care for our patients and our communities. Since 1974, ACCC has been helping oncology professionals adapt to the complex challenges of delivering quality cancer care while responding to regulatory and legislative changes.
ACCC will fulfill its core purpose by pursuing and adhering to these core values:
ACCC members include medical and radiation oncologists, surgeons, cancer program administrators and medical directors, senior hospital executives, practice managers, oncology nurses, pharmacists, radiation therapists, oncology social workers, and cancer program data managers…all members of the cancer care team. They rely on ACCC to bring them information on cancer program management, reimbursement issues, legislative and regulatory changes at the state and national levels, community cancer program standards, NCI-funded community clinical research, hospital alliances and physician relationships, and more.
ACCC Cancer Program Members include more than 670 medical centers, hospitals, cancer programs, and oncology group practices across the United States. In addition, 26 state oncology societies are ACCC chapter members—14 of these are managed by ACCC. Individual physicians, medical and radiation oncologists, and others associated with cancer care, have chosen to become ACCC Individual Members. Together, this group of organizations and individuals sees more than 60 percent of all new cancer patients in the United States each year.
What We Do:
ACCC is here to help oncology professionals adapt to the complex challenges of program management, reimbursement restraints, hospital consolidation and mergers, and legislation and regulations that threaten to compromise the delivery of quality cancer care. In the 1970s ACCC presented the first U.S. meeting about hospital oncology units and hospice care. In the 1980s the Association led the way by presenting the first U.S. meeting on oncology economics and became the chief advocate for NCI’s development of a Community Clinical Oncology Program. Throughout the 1990s, Association support resulted in passage of ACCC’s off-label drug legislation in thirty-nine states. ACCC is the leading oncology policy organization for the cancer care team.
ACCC continues to work closely with members of Congress, government agencies, and other cancer care advocacy organizations to help assure patient access to quality cancer care.
ACCC is well aware that all too often, economic, administrative, or other concerns prevent private-insurance and Medicare patients’ access to quality cancer care. ACCC strongly supports congressional efforts to assure that all cancer patients receive access to quality health care and new therapies. The Association champions the importance of access to cancer specialists, appropriate cancer therapies, and the critical need for investigational trials.
ACCC has developed benefits exclusively for the oncology team:
- authoritative information
- networking opportunities
- meetings and conferences
- advocacy on local and federal issues
- support for state-level oncology organizations
- leadership opportunities
ACCC reaches every member of the oncology team including the key decision makers in oncology programs and practices.